key: cord-1052211-d4gfnn3o
authors: Moe, A.-M. G.; Eriksen, M.; Schjolberg, T.; Haugen, F.
title: SARS-CoV-2 serological findings and exposure risk among employees in school and retail after first and second wave COVID-19 pandemic in Oslo, Norway: a cohort study
date: 2021-04-30
journal: nan
DOI: 10.1101/2021.04.27.21256214
sha: 5b616915a0266f91f5b263f1a2ff1166375e74d2
doc_id: 1052211
cord_uid: d4gfnn3o

Background: During initial phases of the coronavirus disease 2019 (COVID-19) pandemic, many workplaces were affected by closures and various preventive measures intended to limit infections. Here, we characterize and compare in an ambidirectional cohort study SARS-CoV-2 serology among Norwegian school employees and retail employees at baseline following the first epidemiological wave, and at follow-up after a second wave. Methods: We enrolled a cohort of 238 school and retail employees after the first COVID-19 pandemic wave. Self-reported exposure history and serum samples were collected at 10 schools and 15 retail stores in Oslo, Norway, sampled at two time-points, baseline (May 18. to July 2. 2020) and follow-up (Jan 7. to Mar 17. 2021). SARS-CoV-2 antibodies targeting both spike and nucleocapsid were characterized by multiplex microsphere-based serological methods. Results: At baseline, 6 enrolled workers presented with positive SARS-CoV-2 serology (3%; CI [1, 6]; P=0.019), which was significantly higher than the expected 1% prevalence in the general Oslo-population at this time-point. Five of the positive cases were retail employees. However, school and retail groups distributions at baseline were not significantly different as the number of seropositive observations were limited. Due to a school closure effectuated during the first wave, half of the school employees reported [≤]2 days of physical workplace presence per week, while 65% of the retail employees reported [≥]5 days per week. Eight months later, after passing a second epidemiological wave, school and retail groups presented 11 new seropositive cases altogether, but there was still no significant differences between the groups. Physical attendance at the workplace was similar between the groups during the second wave, but some preventive measures against viral transmission at workplaces were different. Self-reported virus diagnostics (RNA) for the same period were compared to the serological data obtained in this study, showing that all but one positive SARS-CoV-2 serological findings arising between baseline and follow-up had been diagnosed with virus testing. Conclusions: After the first wave, distribution of SARS-CoV-2 positive serology was slightly higher than expected in a cohort of school and retail employees. Distribution of infection was not significantly different between the groups at baseline nor at follow-up, even though physical workplace attendance had been different. Nearly all new seropositive cases discovered in this study between baseline and follow-up, had already been diagnosed due to widespread virus testing during the second wave. This highlights the importance of extensive viral testing among workers.

transmission is available from educational settings (Macartney et al. 2020) , the main focus has been 3 on children's role in virus transmission (Lordan et al. 2020) . Studies involving serology indicate that 4 the majority of infections among children have been asymptomatic (Cohen et al. 2020 ; Snape and 5

Viner 2020), but that children seem to spread the virus in the same manner as adults (Jones et al. 6 2020). The transmission of SARS-CoV-2 from asymptomatic cases in general remains unknown. 7

Possibly, this can be clarified using serological methods. 8

From an occupational health perspective, we aimed to gather knowledge about SARS-CoV-2 infections 9

in vulnerable groups of workers in Oslo, Norway. In this study, we aimed to evaluate the distribution 10 of SARS-CoV-2 serology among school and retail employees against workplace factors pertaining to 11 exposure risk and preventive measures. Our approach was to establish a cohort of school employees 12 and retail employees at baseline after the first wave of the COVID-19 pandemic, and to follow the 13 distribution of SARS-CoV-2 serology in these two potentially exposed populations. inhabitants) of COVID-19 in Norway since the start of the pandemic. Oslo county had the highest 28 number of cases; 413 cases/100,000 inhabitants. Only 6.2% of the population had been tested at this 29 point, and the number of actual cases was likely higher (NIPH 2020c). Based on mathematic modelling, 30 NIPH still estimated that less than 1% of the population had been infected by the end of June (NIPH 31 2020a). This estimate was later confirmed by studies of seroprevalence. Based on testing for 32 antibodies for SARS-CoV-2 in 900 samples of residual sera from 9 different laboratories in April/May 33 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. with their serological test results from the baseline session until the follow-up session was finished. 24

Venous blood was drawn from the cubital vein of the antecubital fossa. A flush tube (vacutainer 26 K3EDTA) was used and immediately discarded prior to collecting a total of 20 mL blood from each 27 participant, using BD Vacutainer® Plasma Preparation Tubes (BD PPT™, 9.0 mg K2EDTA, BD, Franklin 28

Lakes, USA) and BD Vacutainer® Serum Separation Tubes (BD SST™ II, 5ml, BD, Franklin Lakes, USA). 29

Tubes were immediately inverted several times. PPT were then centrifuged for 10 minutes at 2,100 × 30 g, SST were left to coagulate at room temperature for minimum 30 minutes, before being centrifuged 31 for 5 minutes at 2,100 x g. Aliquots of plasma and serum were stored at -80°C until analysis. All blood 32 samples were analyzed using Luminex technology. Antigen detection was obtained using xMAP® SARS-33 conducted using software provided by the manufacturer (xMAP SARS-CoV-2, CN-SW77-01 Luminex). 3

The MFI signal for each sample was compared to threshold values defined by the manufacturer of the 4 assay to define a positive or negative test result. A sample will only be defined as SARS-CoV-2 IgG 5 positive if the nucleocapsid (N) target antigen level is above threshold and at least one other target 6 antigen level [S1 spike subunit (S1) and/or the Receptor-binding domain (RBD)] is above threshold. A 7 background control ensures that positive samples are not the result of non-specific binding. Besides 8 using the control kit supplied by the manufacturer, an additional verification of the kit was performed. 9

Samples collectedprior to the pandemic in 2019 were used as negative controls, supplemented with 10 positive controls confirmed either by RNA diagnostic test or serological analysis performed by a 11 different method. For two of the positive controls, we had a negative control from the same person. 12

In conjunction with blood sampling, participants were asked to answer a questionnaire about personal 14 symptoms, previous COVID-19 diagnosis and workplace measures aimed to prevent viral transmission 15 at the workplace. The questionnaire was completed on site via their smartphone or alternatively a 16 tablet. 17

The null hypothesis was expressed as H0: pB=p0=1% and the alternative as H1: pB>p0, where p0 19

represents the cumulated proportion of infected in the general population at baseline (assumed to be 20 1%), and pB the proportion of infected in a subgroup of workers. Estimates showed that n=90 was 21 needed in each group to detect a 10% deviation from p0 with a power of 80% and Type-I error rate of 22 5%. Statistical tests were used as indicated with Graphpad 9 (Binomial Test, Fisher's exact test or 23

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.27.21256214 doi: medRxiv preprint cohort of two working populations. A cohort of potential eligible workers, male and female, age >18 3 years (N=238) were recruited from 10 schools (N=112) and 15 retail stores (N=126) in Oslo, Norway 4 by written consent (Fig. 1) . At baseline, 236 eligible participants completed questionnaires (1 5 withdrew consent, and 1 was excluded due to age <18), serology was obtained from 209 (27 were 6 missing due to failed blood sampling). At follow-up 166 participants completed questionnaires and 7 serology was obtained from 160 (N=6 cases of failed blood sampling, whereas 70 participants were 8 lost from baseline to follow-up and did not respond to contact made by e-mail), i.e. the follow up rate 9 was 70 % (81% for school, 60% for retail). Withdrawal from the study was not a source of participants Schematic overview of participants in the study at baseline and follow-up. 14 (6-9 years); 16% level 5-7 (10-12 years); and 38% level 8-10 (13-15 years First, we assessed the distribution of SARS-CoV-2 infections which had occurred during the first 5 epidemiological wave in retrospect, using serological analyses of blood samples (N=209). For this 6 period, we hypothesized that 1% of the general Oslo-population had been infected, which has been 7 supported (NIPH 2020a). Multiplex microsphere-based SARS-CoV-2 serology of plasma samples 8

showed that baseline distribution of seropositives within the whole workers' cohort deviated from the 9 anticipated level (3% incidence; CI [1, 6]; P=0.019) ( Fig. 2A) . Inspecting the two groups of workers 10 separately, SARS-CoV-2 serology distribution among school employees after the first wave was not 11 significantly different from the assumed distribution (1% incidence; CI [0.1, 6]; P=0.623), whereas the 12 retail employees' distribution was significantly different from the expected (4% incidence; CI [2, 10]; 13 P=0.005). The distributions of positive test results between the two worker's cohorts were compared 14 directly with each other using Fisher's Exact Test. The distribution of positive SARS-CoV-2 serology was 15 not significantly different between the study groups (school employees relative to retail employees: test; P<0.001), due to school closure and remote work ( Fig 2B) . About 50% of school employees 20 reported ≤2 days of physical workplace presence per week, whereas 65% of the retail employees 21 reported ≥5 days. 22 23 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. reported physical attendance at the workplace 3 months prior to the blood sampling at baseline; 7

Mann-Whitney test between the school and retail groups, ***P≤0.001; ND, three non-responders in 8 each group. 9

Second, by prospective design, 8 months later and after the passing of a second epidemiological wave, 11 we identified individuals that had undergone COVID-19 infection by serological analyses of follow-up 12 blood samples collected from the cohort (N=166; loss to follow-up=70). The number of SARS-CoV-2 13 seropositive cases at follow-up was increased from baseline ( Fig 3A) . School incidence was 8% over 14 the 8-month follow-up period, whereas for retail incidence was 6%. Direct comparison of school and 15 retail prevalence at follow-up, showed that there was no significant difference between the groups 16 (Mann-Whitney test; P=0.0219) (Fig 3B) . 22

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Self-reported results of diagnostic SARS-CoV-2 RNA tests prior to baseline were aligned with the 9 serological data to determine the level of undiagnosed SARS-CoV-2 infections in the cohort (Fig. 4) . At 10 baseline, 11 participants self-reported that they had been RNA-tested for ongoing infection; none of 11 these tests had been positive. 196 participants self-reported that they had not been RNA-tested prior 12 to baseline; among these, six individuals tested positive for SARS-CoV-2 serology. Virus testing became 13 more available in the period between baseline and follow-up, hence at follow-up 114 participants self- (Table 2) . 9

Responses were different between school and retail employees: at baseline social distancing, contacts 10 limitation, hand washing/disinfection, and surface washing/disinfection were more frequent among 11 school-than retail employees. On the contrary, retail employees more often reported the use of 12 personal protective equipment (PPE) and protective shields at baseline than school employees did. At 13 follow-up, previous differences in social distancing and surface washing/disinfection were gone. A few (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.27.21256214 doi: medRxiv preprint new knowledge of the infectious distribution in two groups of employees with potentially high 3 occupational exposure to the virus. Antibody measurements showed no significant difference in 4 seropositive prevalence between the two groups at baseline after the first epidemic wave, nor at 5 follow-up after the second wave. Compared to the assumed distribution of cases in the general 6 population we noted at baseline that the number of cases in the cohort was higher than hypothesized. 7

This was due to elevated occurrence of seropositive among retail employees in particular, whereas 8 data on the school employee group showed more moderate levels. This difference in serology among 9

the groups corresponded to a difference in attendance at the workplace during the first wave. A 10 general school closure was enforced in Oslo during the first wave, whereas no general closures were 11 imposed in retail. Matching serology with self-reported diagnostic test results showed low new 12 incidence of undiscovered disease at follow-up. Serology uncovered a minor rate of undiagnosed cases 13 in these populations of Oslo workers, hence the practice and level of diagnostic testing appeared to 14 be adequate. 15

In this ambidirectional cohort study with baseline and follow-up serology, we aimed to observe SARS-16

CoV-2 infections, in retrospect from the origin of the pandemic until baseline (first wave), and 17 prospectively from baseline until follow-up eight months later (second wave). The design has potential 18 to uncover links between infection rates and exposure to occupation as a risk factor. New knowledge 19 from this study confirms that effective alleviation kept COVID-19 transmissions relatively low in the 20

Norwegian population during the first wave. However, low infection rates combined with the modest 21 number of participants recruited in our study imposes limitations on the conclusions we can draw. 22

The power estimates for the retrospective and prospective analyses to uncover the rate of 23 undiagnosed cases in school and retail workers were based on scenarios made in April 2020 when this 24 study was designed. Initially, we feared that the general population would face higher rates of disease 25 transmission. In particular, we anticipated many infected workers in retail, as these individuals had 26 exposure to potential transmission from customers and colleagues. Diagnostic testing capacity was 27 insufficient at this stage, during the first wave, and many parameters were unknown. However, in 28 contrast to the scenarios encountered in many other cities across the world, COVID-19 infection rates 29 stayed relatively low in Oslo. 30

As the approach of this study was to visit workplaces to collect data on occupational health, 31 authorization and organization at the workplaces was required. We achieved a feasible mode of data 32 collection through recruiting participants in groups from a limited number of workplaces, 10 schools 33 and 15 retail stores. These were an arbitrary selection of representative workplaces in Oslo, not a 34 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. On the other hand, with just a few workplaces to recruit from, more focus was put into encouraging 3 participants, as well as streamlining sampling procedures to their work situation. This possibly leads 4 to engaging participants that otherwise would not be motivated to participate, and is therefore likely 5 to reduce selection bias. Potentially, loss to follow-up imposes limitations by affecting study validity, 6 depending on how big of a loss, and how it is distributed. Here, we encountered 30 % loss to follow-7 up in the whole cohort, but most of the lost participants were lost from the group of retail employees. 8

None of the participants withdrew from the study, but several were temporarily laid off, and some 9 had started in other jobs, did not have the time, or did not answer our efforts to schedule follow-up 10 sessions. Differential loss to follow-up can introduce bias that would lead to underestimation of 11 prevalence, and therefore it is important to examine the possibility of an association between 12 participant loss and contraction of COVID-19. Although we cannot exclude the possibility, we do not 13 have observations to support a pattern of diminished work ability in the participants lost to follow-up. 14 Based on the assumption that younger people experience more changing work markets, the lower 15 mean age among retail employees could influence selectively on loss to follow-up. Otherwise, major 16 differences introducing bias seem implausible between the participants lost to follow-up and the 17 participants who completed the follow-up. 18

It is fundamental to this study that antibody measurements are reliable to detect individuals that have this multiplex assay we detect all three simultaneously, which is an advantage, given that high 1 specificity is crucial, particularly with low prevalence. 2 A major finding of the present study was the scarcity of seropositive cases without COVID-19 diagnosis 3 after the second wave. At follow-up only one seropositive participant was undiagnosed with COVID-4 19, the rest had been diagnosed earlier or detected at baseline in our study. The results from the 5 second wave stood in contrast to the results from the first wave; at that point none of the seropositive 6 reported that they had been diagnosed with COVID-19. Hence, with widespread testing nearly all cases 7 are diagnosed. In the beginning of the COVID-19 pandemic in Norway, SARS-CoV-2 diagnostic RT-PCR 8 test capacity was strictly limited. Patients admitted to hospital or other health care facilities with 9 COVID-19 symptoms, health care professionals with symptoms, and symptomatic cases with 10 underlying risk factors were prioritized for testing. Cases with known exposure and non-severe 11 symptoms were not prioritized, and asymptomatic cases were not tested at all. Test capacity gradually 12 improved during 2020. It is therefore likely that cases of COVID-19 infection, both asymptomatic and 13 symptomatic, went undetected during the first wave, spring of 2020. A possible interpretation of our 14 findings uncovers a low rate of asymptomatic cases. It is also possible that with enhanced awareness 15 in the public and low threshold for testing, most cases are discovered. Oran as well as a long summer vacation (June-July). This is reflected in our baseline data; the distribution of 5 seropositive among school employees was not significantly different from the assumed distribution, 6

and school employees reported a low level of physical attendance at work compared to retail 7 employees. Our finding of a higher than expected distribution of seropositive among retail employees 8

is not reflected in the study by Magnusson et al, but one must keep in mind that diagnostic testing 9 was strictly limited during the first wave. The hypothesized 1% infected after the first wave was 10 perhaps an underestimation of the true level, as studies of seroprevalence based on analyses of 11 residual sera in the same period were estimated to be approximately 4% in Oslo (Tunheim G. 2020). 12 Thus, it is also possible that the retail group in our study reflects the general distribution of SARS-CoV-13 2 infections in Oslo better, and that the incidence among school employees was low possibly due to 14 the closure. During the second wave (July-November 2020) the odds of COVID-19 infection were wave, the distribution of seropositive in our cohort is higher than the assumed overall distribution. 20

Stratification of new seropositive cases from baseline to follow-up indicated significantly increased 21 new incidence among the school employees, while this was not the case for retail employees. However, in our study we hardly find any undiagnosed cases in any of the groups studied during the 25 second wave. Furthermore, it has not been clarified what school closure, and subsequent reopening, 26 might contribute to COVID-19 control (Viner et al. 2020). 27

We conclude that seroprevalence in the study cohort was higher than the assumed level after the first 28 wave, mainly caused by a high incidence among retail employees relative to school employees, and 29 possibly linked to workplace attendance/remote work during the first wave. In contrast, attendance 30 at the workplace during the period from baseline to follow-up (second wave) was similar between the 31 two groups. Distribution of positive serology was not statistically different between school and retail 32 employees at baseline nor at follow-up. Among the new cases between baseline and follow-up, we 33 could hardly find any that were undiagnosed; hence the level of diagnostic testing seemed adequate. 34 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 30, 2021. ; https://doi.org/10.1101/2021.04.27.21256214 doi: medRxiv preprint

CoV-2 infections: A living systematic review and meta-analysis

COVID-19 as an 6 occupational disease

COVID-19: Protecting Healthcare Workers is a priority

Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a 11 region heavily affected by COVID-19 pandemic. medRxiv

Immunological 15 memory to SARS-CoV-2 assessed for up to 8 months after infection

Persistence of IgG response to SARS-CoV-2

SARS-CoV-2 21 population-based seroprevalence studies in Europe: a scoping review

Humoral Immune Response to SARS-CoV-2 in Iceland

Profiling Early Humoral analysis of SARS-CoV-2 viral load by patient age. medRxiv

Assessing the extent of SARS-CoV-2 circulation through 7 serological studies

Association between SARS-CoV-2 infection, exposure 9 risk and mental health among a cohort of essential retail workers in the USA. Occupational 10 and Environmental Medicine

Susceptibility to Coronavirus (COVID-19) in Occupational 12 Settings: The Complex Interplay between Individual and Workplace Factors. International 13 Journal of Environmental Research and Public Health

Early Transmission Dynamics 16 in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Clinical and immunological 19 assessment of asymptomatic SARS-CoV-2 infections

Reopening schools during COVID-19

24 (2020) Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort 25 study

COVID-19-epidemien: Kunnskap, situasjon, prognose, risiko og respons i Norge etter 6 uke 26

COVID-19 ukesrapport-uke 11

COVID-19 Ukesrapport -uke 26

Hvor mange har vaert smittet med koronavirus i Oslo og omegn

Statistikk om koronavirus og covid-19

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative 25

Laboratory evaluation of SARS-CoV-2 in the COVID-19